Neurogene NGNE
NASDAQ NGNE
$38.60 +0.99 (+2.63%)
At close: Sep 4, 2026 · 4:00 PM EDT

Neurogene (NGNE) Other Non-Current Assets (2013 - 2026)

Neurogene's (NGNE) quarterly Other Non-Current Assets came in at $1.1 million in Q1 2026, up 20.31% YoY from $896000.0 in Q1 2025, and up 217.99% on a QoQ basis from $339000.0 in Q4 2025.

Analysis

Neurogene (NGNE) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Neurogene (NGNE) has 11 years of Other Non-Current Assets data on file, last reported at $1.1 million in Q1 2026.

  • Quarterly Other Non-Current Assets rose 20.31% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 20.31% YoY) and the FY2025 annual result came in at $339000.0, down 65.23% from the prior year.
  • Other Non-Current Assets grew to $1.1 million in Q1 2026, from $339000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.0 million in Q2 2022 to a low of $300000.0 in Q2 2024.
  • A 5-year average of $917375.0 and a median of $842500.0 in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets slumped 73.81% — and 2025, when it jumped 164.31%.
  • Tracing NGNE's Other Non-Current Assets over 5 years: stood at $1.9 million in 2022, then tumbled by 60.04% to $764000.0 in 2023, then advanced by 27.62% to $975000.0 in 2024, then sank by 65.23% to $339000.0 in 2025, then surged by 217.99% to $1.1 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.1 million (Q1 2026), $339000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Neurogene 864.53 Mn 864.53 Mn - 1.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Mn
Mar 31, 2026 1.08 Mn
Dec 31, 2025 1.03 Mn
Sep 30, 2025 1.06 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 896,000.00
Dec 31, 2024 975,000.00
Sep 30, 2024 789,000.00
Jun 30, 2024 794,000.00
Mar 31, 2024 743,000.00
Dec 31, 2023 764,000.00
Sep 30, 2023 524,000.00
Jun 30, 2023 529,000.00
Mar 31, 2023 905,000.00
Sep 30, 2022 1.91 Mn
Jun 30, 2022 2.02 Mn
Mar 31, 2022 1.95 Mn
Dec 31, 2021 1.93 Mn
Sep 30, 2021 1.99 Mn
Jun 30, 2021 1.93 Mn